Form 4 for DBD DIEBOLD NIXDORF, Inc
Accepted 2026-01-21 00:00:00 ET · period of report 2026-01-19 · accession 0001917170-26-000002 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-01-21 | 2026-01-19 | DBD | Marquez Octavio | Pres, CEO, Dir | F - Tax | $69.91 | -3,136 | 191.6K | -2% | -$219.2K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-01-19 | F | D | 3,136 | $69.91 | 191,639 | D | — | — | (F1) Shares withheld pursuant to exercise of tax withholding right under the 2023 Equity and Incentive Plan, as amended. (F2) Number includes Restricted Stock Units. |